RhumbLine Advisers
ORGS

RhumbLine Advisers’s Orgenesis Inc. Common Stock ORGS Stock Holding History

RhumbLine Advisers’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,946
Closed -$112K – 3127
2021
Q1 		$112K Buy
1,946
+12
+0.6% +$782 ﹤0.01% 2922
2020
Q4 		$87K Buy
1,934
+348
+22% +$16.8K ﹤0.01% 2979
2020
Q3 		$80K Sell
1,586
-514
-24% -$27.9K ﹤0.01% 2908
2020
Q2 		$128K Buy
+2,100
New +$127K ﹤0.01% 2913

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

RhumbLine Advisers's ORGS Position: Q2 2021 in Review

RhumbLine Advisers sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2021, closing a stake of 1,946 shares — an estimated $112K sold.

RhumbLine Advisers first reported a position in ORGS in Q2 2020 and held it in 4 quarters. The position peaked at $128K in Q2 2020. 33 funds tracked by Wall St. Rank hold ORGS as of Q2 2021.

  • RhumbLine Advisers reported no remaining Orgenesis Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • RhumbLine Advisers sold 1,946 Orgenesis Inc. Common Stock shares in Q2 2021, an estimated $112K.
  • RhumbLine Advisers first reported a position in Orgenesis Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • RhumbLine Advisers's Orgenesis Inc. Common Stock position peaked at $128K in Q2 2020.
  • 33 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2021.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.